Knee Replacement Surgery

Patients with autoimmune rheumatic diseases who are undergoing elective hip or knee arthroplasty should maintain their usual doses of methotrexate, leflunomide, hydroxychloroquine, sulfasalazine and apremilast , according to new guidelines.

Joint replacement in patients with inflammatory arthritis is often beset with pitfalls like disease flares and infectious complications, and up until recently, the emergence new treatments were rendering the current guidelines outdated.

A personalized referral system dubbed Support and Treatment After Replacement, or STAR, is cost effective and improves chronic pain after total knee replacement over a 1-year period, according to data published in The Lancet Rheumatology.

Milvexian for prevention of venous thromboembolism in patients undergoing total knee arthroplasty.

Smith & Nephew has announced acquisition of Engage Surgical and its cementless partial knee system, according to a company press release.

In patients who underwent knee arthroplasty, milvexian, a novel factor XIa inhibitor, was effective at preventing venous thromboembolism and was linked to a low rate of bleeding, researchers reported.

Zimmer Biomet Holdings Inc. and Canary Medical announced FDA de novo classification grant and authorization to market the tibial extension for the Persona IQ, a smart knee implant for total knee replacement surgery.

A single IV dose of the factor XI monoclonal antibody abelacimab appeared superior to daily enoxaparin for preventing venous thromboembolism after total knee arthroplasty, according to randomized study results.

CMS data revealed that 78% of payments to rheumatologists from the pharmaceutical industry in 2014 to 2019 went to just 6% of recipients. On average, men received more than twice as much as women.

Just 23% of Medicare beneficiaries with osteoarthritis who eventually underwent knee replacement ever had a physical therapy visit, according to data published in Arthritis & Rheumatology.